Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

CNS High-Grade Neuroepithelial Tumour with BCOR Alteration

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Oct 10, 2025

What is CNS High-Grade Neuroepithelial Tumour with BCOR Alteration?

CNS High-Grade Neuroepithelial Tumour with BCOR alteration is a very rare and aggressive brain or spinal cord cancer. It mainly affects children and young adults. “CNS” refers to the central nervous system, which includes the brain and spinal cord.

“High-grade” means that the tumour grows quickly and tends to spread. “BCOR” is a gene that, when altered or mutated, causes the cells to grow abnormally and become cancerous. This tumour has been newly recognised and has been added to recent medical classifications based on its unique genetic alteration.

Symptoms

Patients with this tumour may start having symptoms depending on where the tumour is located. Common signs include headaches, nausea, vomiting, vision problems, balance issues, seizures, or weakness in different parts of the body. In children, parents may also notice personality changes, school difficulties, or delayed development.

Diagnosis

To diagnose this condition, doctors use brain imaging tests like MRI or CT scans to locate the tumour. A sample of the tumour (biopsy) is examined under a microscope, and special genetic tests are performed to detect the BCOR alteration. This helps doctors confirm the exact type of tumour.

Treatment

Treatment usually begins with surgery to remove as much of the tumour as possible. However, complete removal is often hard because the tumour can be located deep within the brain or spinal cord. After surgery, chemotherapy and radiation are given to kill the remaining cancer cells. In some cases, doctors may suggest joining clinical trials for new treatments targeting BCOR mutations.

Prognosis

The prognosis for this tumour is generally poor, as it tends to grow fast and come back even after treatment. But research is ongoing, and doctors are working on targeted therapies that may improve survival. Regular monitoring and supportive care are important for managing this challenging condition.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousOur New Resource Page for Diffuse Leptomeningeal Glioneuronal Tumour (DLGNT)
NextOur New Resource Page for CNS High-Grade Neuroepithelial Tumour with BCOR Alteration

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter